| |
|
|
|
|
|
|
|||
|
Blood, 15 September 2005, Vol. 106, No. 6, pp. 2147-2155. Prepublished online as a Blood First Edition Paper on May 24, 2005; DOI 10.1182/blood-2004-11-4330.
Submitted November 12, 2004
Department of Hematology, Dokkyo University School of Medicine, Tochigi, Japan * Corresponding author; email: kinukom-tky{at}umin.ac.jp.
The AML1/Evi-1 chimeric gene is created by the t(3;21)(q26;q22) chromosomal translocation seen in patients with leukemic transformation of myelodysplastic syndrome or blastic crisis of chronic myelogenous leukemia. We knocked-in the AML1/Evi-1 chimeric gene into mouse AML1 genomic locus to explore its effect in developmental hematopoiesis in vivo. AML1/Evi-1/+ embryo showed defective hematopoiesis in the fetal liver, and died around E13.5 due to hemorrhage in the central nervous system. The peripheral blood had yolk sac-derived nucleated erythroblasts but lacked erythrocytes of the definitive origin. While E12.5 fetal liver contained progenitors for macrophage only, E13.5 fetal liver contained multi-lineage progenitors capable of differentiating into dysplastic myelocyte and megakaryocyte. No erythroid progenitor was detected in E12.5 or E13.5 fetal liver. Hematopoietic progenitor from E13.5 AML1/Evi-1/+ fetal liver was highly self-renewal compared to that from wild-type liver. Maintained expression of PU.1 gene and decreased expression of LMO2 and SCL genes may explain the aberrant hematopoiesis in AML1/Evi-1/+ fetal liver.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||